Google
RDY 株価分析 — DR. REDDY’S LABORATORIES LTD ADR (Healthcare >> Drug Manufacturers - Specialty & Generic)
RDY に関するよくある質問
RDYのPER（株価収益率）は？
DR. REDDY’S LABORATORIES LTD ADR（RDY）は現在PER 0.30倍で取引されています。
RDYのROE（自己資本利益率）は？
DR. REDDY’S LABORATORIES LTD ADRのROEは8.65%です。
RDYの配当利回りは？
DR. REDDY’S LABORATORIES LTD ADRの配当利回りは0.70%です。
RDYの品質スコア（Quality Score）は？
当社のAIはRDYの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
RDYは今が買い時ですか？
当社AIのタイミングスコアは100点中26点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
RDYはどのセクターに属しますか？
DR. REDDY’S LABORATORIES LTD ADRはHealthcare >> Drug Manufacturers - Specialty & Genericセクターに分類されます（NYSE市場）
RDY AI Analysis Summary
Our AI summary for RDY: DR. REDDY’S LABORATORIES LTD ADR (NYSE), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 0.30, ROE of 8.65%, a dividend yield of 0.70%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 11.85
Price
0.02
(0.17%)
Day Change
|
|
|---|
RDY, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
50% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 74 |
| Magic Formula Rank by ROA |
171
|
| Magic Formula Rank by ROE |
171
|
| Magic Formula Rank by ROIC |
153
|
| Price | 11.85 |
| PBV / Sector |
0.03 / 3.22
GREAT
|
| Earning Per Share | 39.88 |
| PE / Sector |
0.30 / 29.79
GREAT
|
| PEG or PE/Growth / Sector |
N/A / 0.13
|
| Average 1M Daily Value |
35.51 M
GREAT
|
| Average 1W Daily Value |
33.12 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
58% |
| ポイントになる統計 |
|
58% |
| 配当 |
|
41% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:24 |
| Symbol | RDY |
| Name | DR. REDDY’S LABORATORIES LTD ADR |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NYSE |
| Listed Shares | 833.00 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 9,854.39 / 10,754.62 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 8-2-337, Road No. 3, Hyderabad, India, 500034
Phone: 91 40 4900 2900
Website: https://www.drreddys.com
Employees: 27,527
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. Its Others segment engages in developing therapies in the fields of oncology and inflammation; and research, development, and commercialization of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines, vitamins and minerals, and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
